Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Mechanistic context: prebiotic and metabolic effects CP can exhibit prebiotic potential by interacting with the gut microbiota, leading to the release of SCFA and branched-chain fatty acids (BCFA) that can improve symptoms associated with metabolic diseases (Reference Ren, Yue and Zhang107)
Gastrointestinal Reactions (Reported/Theoretical) : Some reports suggest possible nausea or digestive discomfort, although consistent human data are lacking
Glucagon-Like Peptide-1 Receptor Agonists Are Promising for the Treatment of Brain Diseases: an Outlook from the Perspective of Integrative Physiology
But the human data gap is real
US$ 22.99
US$ 29.69
US$ 20.74
US$ 27.47
